By selecting the Yes option, Leave Amgen.co.uk option, you understand that you are leaving the corporate page of Amgen UK and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen has a strong track record of building strategic partnerships with health systems worldwide, which are integral for our mission ‘to serve patients’ by enhancing healthcare and improving patient outcomes. These partnerships span a wide array of initiatives, focusing on innovative solutions to healthcare challenges.
In the UK, we aim to create value by addressing pressing health issues with the greatest potential for improvement. That's why we work with the NHS and other healthcare organisations to develop new ways of caring for patients.
We have the time, resources and drive to invest in understanding the healthcare policies, political, and economic forces and bureaucratic barriers that can get in the way of keeping people healthy. With the patient at the heart, Amgen uses data and experience to examine environmental factors at local, regional, and national levels to test hypotheses and develop solutions that can show meaningful improvement.
Demonstrating a comprehensive approach to risk prediction and prevention for cardiovascular disease (CVD) patients.
